Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 3/20 | 0.71 |
| ▸ | TSHR | P16473 | 3/20 | 0.65 |
| ▸ | CASP1 | P29466 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | PYGL | P06737 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.49 |
| ▸ | TTR | P02766 | 2/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | CDC25A | P30304 | 1/20 | 0.46 |
| ▸ | CDC25B | P30305 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28775847 | 0.84 | KDM4E (0.73) | SRD5A2TSHRCASP1SMN1; SMN2KDM4E | |
| SCHEMBL8437570 | 0.84 | SRD5A2 (0.96) | SRD5A2TSHRCASP1SMN1; SMN2MAPT | |
| SCHEMBL5311692 | 0.84 | KDM4E (0.77) | SRD5A2TSHRKDM4EMAPTRAB9A | |
| SCHEMBL9718447 | 0.83 | KDM4E (0.67) | SRD5A2TSHRKDM4EPOLBKMT2A | |
| SCHEMBL8864622 | 0.83 | SMN1; SMN2 (0.69) | SRD5A2TSHRCASP1SMN1; SMN2MAPT | |
| SCHEMBL195020 | 0.82 | SMN1; SMN2 (0.71) | SRD5A2TSHRCASP1SMN1; SMN2KDM4E | |
| SCHEMBL30185351 | 0.82 | SMN1; SMN2 (0.71) | SRD5A2TSHRCASP1SMN1; SMN2KDM4E | |
| SCHEMBL9721182 | 0.81 | ALDH1A1 (0.62) | SRD5A2TSHRCASP1SMN1; SMN2KDM4E | |
| SCHEMBL11876536 | 0.81 | TSHR (0.72) | SRD5A2TSHRCASP1SMN1; SMN2KDM4E | |
| SCHEMBL111279 | 0.80 | TSHR (1.00) | SRD5A2TSHRCASP1SMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 252 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240199653-A1 | METHOD FOR FORMING AN ELECTRICALLY CONDUCTIVE METAL ORGANIC FRAMEWORK COMPOSITE | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-06-20 | — | — | US | claimed |
| WO-2024123903-A1 | SORBENT COMPOSITIONS, SYSTEMS, AND METHODS | GE INFRASTRUCTURE TECHNOLOGY LLC (US) | 2024-06-13 | — | — | WO | claimed |
| US-20200291045-A1 | CONDUCTIVITY ENHANCEMENT OF MOFS VIA DEVELOPMENT OF MOFPOLYMER COMPOSITE MATERIAL | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2020-09-17 | — | — | US | claimed |
| EP-2739169-B1 | POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS | MASSACHUSETTS INST TECHNOLOGY (US) | 2019-06-12 | — | — | EP | claimed |
| US-20140311507-A1 | Porous Catalytic Matrices for Elimination of Toxicants Found in Tobacco Combustion Products | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2014-10-23 | — | — | US | claimed |
| EP-2739169-A2 | POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS | Massachusetts Institute Of Technology (US) | 2014-06-11 | — | — | EP | claimed |
| WO-2013019865-A2 | POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2013-02-07 | — | — | WO | claimed |
| WO-2025093597-A1 | METHOD AND APPARATUS FOR CARBON DIOXIDE SEPARATION | MOF Technologies Limited (GB) | 2025-05-08 | — | — | WO | disclosed |
| EP-4514510-A1 | METHOD AND APPARATUS FOR CARBON DIOXIDE SEPARATION | MOF Technologies Limited (GB) | 2025-03-05 | — | — | EP | disclosed |
| US-12227526-B2 | Metal-organic framework materials comprising a diimine scaffold and methods for production thereof | ExxonMobil Technology and Engineering Company (US) | 2025-02-18 | — | — | US | disclosed |
| US-20250050311-A1 | METHOD AND APPARATUS FOR CARBON DIOXIDE SEPARATION | MOF Technologies Limited (GB) | 2025-02-13 | — | — | US | disclosed |
| EP-3947396-B1 | METAL-ORGANIC FRAMEWORK MATERIALS COMPRISING A DIIMINE SCAFFOLD AND METHODS FOR PRODUCTION THEREOF | EXXONMOBIL TECHNOLOGY & ENGINEERING COMPANY (US) | 2024-12-11 | — | — | EP | disclosed |
| US-12097481-B2 | Process for preparing metal organic frameworks having improved water stability | MOF Technologies Limited (GB) | 2024-09-24 | — | — | US | disclosed |
| US-20060210458-A1 | bringing the liquid into contact with at least one sorbent comprising a porous metal-organic framework, the framework taking up the liquid and comprising at least one at least bidentate organic compound having a coordinate bond to at least one metal ion | BASF AKTIENGESELLSCHAFT (DE) | 2006-09-21 | — | — | US | disclosed |
| EP-1702925-A1 | absorption of liquids by metal organic framework materials | BASF AKTIENGESELLSCHAFT (DE) | 2006-09-20 | — | — | EP | disclosed |
| EP-1687462-A1 | METHOD FOR ELECTROCHEMICAL PRODUCTION OF A CRYSTALLINE POROUS METAL ORGANIC SKELETON MATERIAL | BASF AKTIENGESELLSCHAFT (DE) | 2006-08-09 | — | — | EP | disclosed |
| WO-2006072573-A2 | ADSORPTIVE PRODUCTION OF XENON FROM KRYPTON/XENON GAS MIXTURES | BASF AKTIENGESELLSCHAFT (DE) | 2006-07-13 | — | — | WO | disclosed |
| EP-1674555-A1 | Concentration of methane in methane containing gas mixtures by adsorption | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-28 | — | — | EP | disclosed |
| US-20050154222-A1 | Process for preparing an organometallic framework material | BASF AKTIENGESELLSCHAFT (DE) | 2005-07-14 | — | — | US | disclosed |
| WO-2005049892-A1 | METHOD FOR ELECTROCHEMICAL PRODUCTION OF A CRYSTALLINE POROUS METAL ORGANIC SKELETON MATERIAL | BASF AKTIENGESELLSCHAFT (DE) | 2005-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12227526-B2 | Metal-organic framework materials comprising a diimine scaffold and methods for production thereof | PICALM, ILK, CAD | SRD5A2 3162/4885TSHR 4193/4885CASP1 1155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.